Cydex Pharmaceuticals Inc
Founded 1987 · 1 known investors
Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.
Investors · 1
Competitors · 2
by search overlapCelldex Therapeutics, Inc.8 shared keywordsCelldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.
1Mg7 shared keywordsTata 1mg is India's leading online pharmacy and healthcare platform that offers medicines, lab tests, doctor consultations, and cancer care services. The company operates a digital marketplace serving Indian consumers seeking pharmaceuticals, diagnostic testing, and medical advice.
Companies competing with Cydex Pharmaceuticals Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cydex Pharmaceuticals Inc do?
- Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.
- Who are Cydex Pharmaceuticals Inc's investors?
- Cydex Pharmaceuticals Inc's investors include RiverVest Venture Partners.